Arrhythmia Research Technology (HRT)

Add to Watchlists Create an Alert
2.59 +0.05  +1.97%   AMEX May 22, 8:00PM BATS Real time Currency in USD

Arrhythmia Research Technology Cash from Financing Quarterly:

0.2355M for Sept. 30, 2012
View Full Chart

Arrhythmia Research Technology Cash from Financing Quarterly Chart

    Arrhythmia Research Technology Historical Cash from Financing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Sept. 30, 2012 0.2355M
    June 30, 2012 0.888M
    March 31, 2012 0.4391M
    Dec. 31, 2011 -0.0082M
    Sept. 30, 2011 -0.1682M
    June 30, 2011 0.00
    March 31, 2011 -0.1682M
    Dec. 31, 2010 0.00
    Sept. 30, 2010 -0.1751M
    June 30, 2010 0.00
    March 31, 2010 -0.1613M
    Dec. 31, 2009 0.00
    Sept. 30, 2009 -0.5908M
    June 30, 2009 -0.0569M
    March 31, 2009 -0.0235M
    Dec. 31, 2008 -0.077M
    Sept. 30, 2008 -0.024M
    June 30, 2008 -0.0245M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
       
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro
    June 30, 2000 Go Pro

    About Cash From Financing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
    Learn More

    Get data for

    HRT Cash from Financing Quarterly Benchmarks

    Companies
    Abiomed
    Guided Therapeutics 0.04M
    Span-America Medical

    HRT Cash from Financing Quarterly Rankings

    Overall 80th percentile
    1562 of 8005
    Sector 64th percentile
    244 of 686 in Healthcare
    Industry 72nd percentile
    26 of 93 in Medical Devices

    HRT Cash from Financing Quarterly Range, Past 5 Years

    Minimum -0.5908M Sep 2009
    Maximum 0.8880M Jun 2012
    Average 0.0047M